We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Child Throat Bacteria Also Found in Joint Infections

By LabMedica International staff writers
Posted on 19 Sep 2017
Using sensitive diagnostics, researchers have found that the presence of the Kingella kingae in children's throats was strongly linked to bone and joint infection with the same bacterium.

Previously, most bone and joint bacterial infections in children were thought to be caused by Staphylococcus, Streptococcus, or Haemophilus influenzae Type B bacteria, and were treated with long-term antibiotics and/or surgery. More...
Over the last years, new highly sensitive techniques have allowed more precise identification of the bacteria responsible for these infections.

The study – a collaboration between two pediatric university hospital centers in Montreal, Canada, and Geneva, Switzerland – included 77 children aged 6 months to 4 years of age admitted for suspected bone or joint infection and 286 controls. Of the suspected infections, 65 children had confirmed bone or joint infection.

"Using improved diagnostic methods, our study found that the vast majority of children younger than 4 years old suffering from a bone or joint infection were infected by Kingella kingae bacteria," stated Dr. Jocelyn Gravel, of the Mother & Child University Hospital Center Sainte-Justine, University of Montreal (Montréal, Quebec, Canada), "More importantly, we discovered that 70% of children who had a bone/joint infection carried these bacteria in their throats, while it is uncommon in uninfected children (only 6%)."

These results are especially important as the proportion of unknown pathogen was very high in previous studies. Now, using innovative diagnosis methods, this study demonstrated the K. kingae is not uncommon. Rather, it is by far the most common pathogen for bone or joint infection in children.

"Based on this study, we plan to change the way we investigate children at risk of bone/joint infection, because the identification of K. kingae in the throat of a child with a suspected bone infection will point towards K. kingae as the culprit. This may decrease the number of other tests performed to identify the pathogen."

The authors note that it was a small study and further studies are needed. In a related commentary in CMAJ, Drs. Romain Basmaci and Stéphane Bonacorsi, Louis-Mourier Hospital (Colombes, France), caution that, although the findings of the study show a strong association between throat infection of K. kingae and bone/joint infection, "with a carriage rate among healthy children as high as 10% in some countries, relying on oropharyngeal detection as a proxy for diagnosis in the case of a joint infection would result in a high false-positive diagnosis."

The study, by Gravel J et al, and the above-mentioned related commentary, were published September 5, 2017, in CMAJ (Canadian Medical Association Journal).

Related Links:
Mother & Child University Hospital Center Sainte-Justine


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.